InvestorsHub Logo
Followers 13
Posts 1260
Boards Moderated 0
Alias Born 04/29/2011

Re: DewDiligence post# 509

Monday, 03/13/2017 11:46:45 AM

Monday, March 13, 2017 11:46:45 AM

Post# of 625
Dont forget, that OCALIVA has received approbation from FDA only because there was not other treatment for PBC. And, the doses have been reduced.

Dont forget that OCALIVA increase bad cholesterol, it means, it can increase the risk of cardiovascular issue ...

Maybe you knew Georges Michaël ...

Anyway, when you have choice to take OCALIVA with all undesire effects, or Elafibranor, what would you to take ?

What would you prefer that your doctor give you ?

For me choice is fast ... It s not only a question of money, but public health ...

Risk of cancer, increase of bad cholesterol, prurit .. only attack the Fibrosis, and not the NASH, while Fibrosis is a consequence of NASH ...

Ok, you are saying not a big deal ... We ll see that ...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ICPT News